# Reishilab Sdn Bhd · 99-39 · MALAYSIA — FDA import alert red lists: firms subject to detention without physical examination

For Reishilab Sdn Bhd · 99-39 · MALAYSIA, import alert is 99-39; import alert name is Detention Without Physical Examination of Imported Food Products That Appear to Be Misbranded; country is MALAYSIA; product is Ashiguard Capsules | Ashiguard Capsules | Ashiguard Capsules | Ashiguard Capsules; product code is 54 A - - 99 Vitamin, N.E.C. | 54 F - - 03 Angelica (Herbal & Botanicals, not Teas) | 54 F - - 99 Herbals & Botanicals (not Teas), N.E.C. | 54 Y - - 99 Vitamin, Mineral, Proteins and Unconventional Dietary Specialities For Humans and Animals, N.E.C; date published is 05/20/2019; address is No 5 Jalan 4/2 , Hulu Langat, Selangor MALAYSIA, verified against its source on 2026-09-16.

- **Firm:** Reishilab Sdn Bhd _(verified: appears in the quote below)_
- **Import alert:** 99-39
- **Import alert name:** Detention Without Physical Examination of Imported Food Products That Appear to Be Misbranded
- **Country:** MALAYSIA _(verified: appears in the quote below)_
- **Address:** No 5 Jalan 4/2 , Hulu Langat, Selangor MALAYSIA _(verified: appears in the quote below)_
- **Date published:** 05/20/2019 _(verified: appears in the quote below)_
- **Product code:** 54 A - - 99 Vitamin, N.E.C. | 54 F - - 03 Angelica (Herbal & Botanicals, not Teas) | 54 F - - 99 Herbals & Botanicals (not Teas), N.E.C. | 54 Y - - 99 Vitamin, Mineral, Proteins and Unconventional Dietary Specialities For Humans and Animals, N.E.C. _(verified: each item appears in the quote below)_
- **Product:** Ashiguard Capsules | Ashiguard Capsules | Ashiguard Capsules | Ashiguard Capsules _(verified: each item appears in the quote below)_
- **FDA notes:** The article is subject to refusal of admission pursuant to section 801(a)(3) in that it appears to be misbranded within the meaning of sections: 403(q) in that the label fails to present nutrition information (Supplement Facts). 403(q) because the serving size is not declared on the product label. 403(y) of the Act [21 U.S.C. § 343(y)] in that the label fails to bear a domestic address or domestic phone number through which the responsible person may receive a report of a serious adverse event. 403 (s)(2)(B) of the Act because the label fails to include a statement of identity. 403(i)(2) in that the product label fails to declare the common or usual name or Latin binomial of each ingredient. | The article is subject to refusal of admission pursuant to section 801(a)(3) in that it appears to be misbranded within the meaning of sections: 403(q) in that the label fails to present nutrition information (Supplement Facts). 403(q) because the serving size is not declared on the product label. 403(y) of the Act [21 U.S.C. § 343(y)] in that the label fails to bear a domestic address or domestic phone number through which the responsible person may receive a report of a serious adverse event. 403 (s)(2)(B) of the Act because the label fails to include a statement of identity. 403(i)(2) in that the product label fails to declare the common or usual name or Latin binomial of each ingredient. | The article is subject to refusal of admission pursuant to section 801(a)(3) in that it appears to be misbranded within the meaning of sections: 403(q) in that the label fails to present nutrition information (Supplement Facts). 403(q) because the serving size is not declared on the product label. 403(y) of the Act [21 U.S.C. § 343(y)] in that the label fails to bear a domestic address or domestic phone number through which the responsible person may receive a report of a serious adverse event. 403 (s)(2)(B) of the Act because the label fails to include a statement of identity. 403(i)(2) in that the product label fails to declare the common or usual name or Latin binomial of each ingredient. | The article is subject to refusal of admission pursuant to section 801(a)(3) in that it appears to be misbranded within the meaning of sections: 403(q) in that the label fails to present nutrition information (Supplement Facts). 403(q) because the serving size is not declared on the product label. 403(y) of the Act [21 U.S.C. § 343(y)] in that the label fails to bear a domestic address or domestic phone number through which the responsible person may receive a report of a serious adverse event. 403 (s)(2)(B) of the Act because the label fails to include a statement of identity. 403(i)(2) in that the product label fails to declare the common or usual name or Latin binomial of each ingredient. _(verified: each item appears in the quote below)_

## What the source says

> Reishilab Sdn Bhd Date Published : 05/20/2019 No 5 Jalan 4/2 , Hulu Langat, Selangor MALAYSIA 54 A - - 99 Vitamin, N.E.C. Date Published: 05/20/2019 Desc: Ashiguard Capsules Notes: The article is subject to refusal of admission pursuant to section 801(a)(3) in that it appears to be misbranded within the meaning of sections: 403(q) in that the label fails to present nutrition information (Supplement Facts). 403(q) because the serving size is not declared on the product label. 403(y) of the Act [21 U.S.C. § 343(y)] in that the label fails to bear a domestic address or domestic phone number through which the responsible person may receive a report of a serious adverse event. 403 (s)(2)(B) of the Act because the label fails to include a statement of identity. 403(i)(2) in that the product label fails to declare the common or usual name or Latin binomial of each ingredient. 54 F - - 03 Angelica (Herbal & Botanicals, not Teas) Date Published: 05/20/2019 Desc: Ashiguard Capsules Notes: The article is subject to refusal of admission pursuant to section 801(a)(3) in that it appears to be misbranded within the meaning of sections: 403(q) in that the label fails to present nutrition information (Supplement Facts). 403(q) because the serving size is not declared on the product label. 403(y) of the Act [21 U.S.C. § 343(y)] in that the label fails to bear a domestic address or domestic phone number through which the responsible person may receive a report of a serious adverse event. 403 (s)(2)(B) of the Act because the label fails to include a statement of identity. 403(i)(2) in that the product label fails to declare the common or usual name or Latin binomial of each ingredient. 54 F - - 99 Herbals & Botanicals (not Teas), N.E.C. Date Published: 05/20/2019 Desc: Ashiguard Capsules Notes: The article is subject to refusal of admission pursuant to section 801(a)(3) in that it appears to be misbranded within the meaning of sections: 403(q) in that the label fails to present nutrition information (Supplement Facts). 403(q) because the serving size is not declared on the product label. 403(y) of the Act [21 U.S.C. § 343(y)] in that the label fails to bear a domestic address or domestic phone number through which the responsible person may receive a report of a serious adverse event. 403 (s)(2)(B) of the Act because the label fails to include a statement of identity. 403(i)(2) in that the product label fails to declare the common or usual name or Latin binomial of each ingredient. 54 Y - - 99 Vitamin, Mineral, Proteins and Unconventional Dietary Specialities For Humans and Animals, N.E.C. Date Published: 05/20/2019 Desc: Ashiguard Capsules Notes: The article is subject to refusal of admission pursuant to section 801(a)(3) in that it appears to be misbranded within the meaning of sections: 403(q) in that the label fails to present nutrition information (Supplement Facts). 403(q) because the serving size is not declared on the product label. 403(y) of the Act [21 U.S.C. § 343(y)] in that the label fails to bear a domestic address or domestic phone number through which the responsible person may receive a report of a serious adverse event. 403 (s)(2)(B) of the Act because the label fails to include a statement of identity. 403(i)(2) in that the product label fails to declare the common or usual name or Latin binomial of each ingredient.

## Source

- https://www.accessdata.fda.gov/cms_ia/importalert_1144.html

Last verified: 2026-09-16. Review by: 2026-11-15.
Part of [FDA import alert red lists: firms subject to detention without physical examination](https://referencesource.org/fda-import-alert-red-list/).